Artelo is advancing programs for patients with various serious diseases. We believe our unique technologies may lead to meaningful therapies for patients who currently have few or no treatment options.
Below you can find information about our current clinical studies, the diseases and conditions we aim to treat, and patient advocacy.
Cancer Anorexia / Cancer Anorexia Cachexia Syndrome (CACS)
The devastating effects of cancer and/or cancer chemotherapies which result in weight loss (anorexia) and muscle wasting (cachexia)
Currently, ART27.13 is the focus of a phase 1b/2a, randomized, placebo-controlled trial called the Cancer Appetite Recovery Study (CAReS Trial). The CAReS Trial aims to determine a safe and effective dose as well as activity of ART27.13 in terms of lean body mass, weight gain, and improvement of anorexia. CAReS is currently enrolling patients at numerous sites.
The Unmet Need
The CAReS Trial
Hope for the Future
Chemotherapy-Induced Peripheral Neuropathy (CIPN)
A very common complication arising from chemotherapy in which a patient experiences significant pain and inflammation in their extremeties